Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 141 - 150 of 244 for simcere. (0.12 seconds)

Charles River Labs noted a slowdown in the worldwide CRO...
aTyr Pharma will use a Hong Kong lab to help develop...
Hutchison MediPharma Limited sold an option on its...
ChinaBio® Today profiled Sinoasis Pharmaceuticals,...
Simcere Pharma (先声药业) will...
Jiangsu Hengrui Medicine received FDA approval to begin...
China has ordered 7.3 million doses of H1N1 flu vaccine...
Jiangsu Yanshen Biological Technology Stock Co. was given...
Boehringer Ingelheim will invest $149 million in China...
PPD, Inc., a US-based CRO, agreed to acquire Excel...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here